Peer Review History
| Original SubmissionJune 19, 2024 |
|---|
|
PONE-D-24-23176Modeling Survival Time to Death among Under-Five Children in Africa: Application of Lognormal AFT Gamma Shared Frailty Parametric Survival Regression ModelPLOS ONE Dear Dr. Liyew, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been evaluated by two reviewers, and their comments are available below. The reviewers have raised a number of major concerns. They feel the manuscript should outline a clearly-defined research question, and they request improvements to the reporting of methodological aspects of the study and result, as well as improved framing in the introduction. Could you please carefully revise the manuscript to address all comments raised? Please submit your revised manuscript by Nov 03 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Avanti Dey, PHD Staff Editor PLOS ONE Journal Requirements: Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors seem to have rushed to submit the manuscript prematurely. In its present form, the manus is too scattered and disorganized with Of the 44 - 2 = 42 pages from Introduction to Conclusion 24 pages (57 %) are or include tables. More seriously, these 24 pages appear in the body of the manuscript, not on Appendix which could allow for better reading of the text. To the surprise of this reviewer, the authors have pasted the life-table (or Kaplan-Meier) estimates of the survivor function on 4 pages (pages 17-20) and the corresponding estimates of the hazard function on another 4 pages (page 21 - 24). This indicates they are well versed with how results are presented in scientific articles. Seasoned researchers could have chosen to present summary statistics of the functions in a table and possibly plot the surivivor and hazard functions on one page - thereby reducing their 8 pages to 1-2 pages. The manuscript seems to have 4-5 Sections: - Introduction on pages 3-4 (which should be 1-2), - Methods and Materials on pages 5-8 (should be 3-6) - Results on pages 9-39!!! (should be 7-37) - Discussion on pages 39 - 43 (should be 37-41) - Conclusion on page 44 (should be 42) There also seems to be many sub-sections within each section. Unfortunately, it is not possible to distinguish which is a Section and which is a sub-section because they are neither numbered not can be identified by their font-sizes and/or font-types. The above make it hard or impossible to extract the merits (if any) of the manuscript. The authors, therefore, need to, at least, do major revision to polish their manuscript if they believe they have something worth publishing in journals like PLOS ONE. Below are some recommendations: 1. They can begin with the title. First it's not appropriate to use AFT in the title (though the reviewer knows it means Accelerated Failure Time). Further, the title can be modified (shortened) depending on whether the focus is on methodology or the substantive issues. For instance, "Parametric Modeling of Under-5 Survival Among 30 African Countries" or "Under-5 Survival in 30 African Countries: The Use of Parametric Models, etc... can be some alternatives. 2. They also need to justify the choice of log-normal model for the survival time and gamma model for the frailty. They also need to explain why they need failty models (what new insights do they provide compared to standard models). 3. They need to write their manuscript concisely and coherently with well organized and clear sections and subsections. 4. Tables and plots of relevant results should be put in an Appendix (at least at the stage of review). 5. Make it clear right at the outset the expected contribution of the study, for instance, is it a methodological contribution (to show the merits of parametric modeling), or a substantive contribution to report the status of under-5 mortality in the 30 countries (or both)? There is much more to be done but I hope the above will suffice as a guideline. Reviewer #2: Date: 14-sep-2024 General Comments Thank you for inviting me to review a manuscript entitled “Modeling Survival Time to Death among Under-Five Children in Africa: Application of Lognormal AFT Gamma Shared Frailty Parametric Survival Regression Model”. This is an interesting study, and the authors have collected a good dataset using the critical advantage methodology. The paper is generally well written and structured. However, from my point of view, the manuscript has some shortcoming with respect to some dataset analyses and text, and I feel this good dataset has not been used to its full extent. Underneath, the reviewer has provided several remarks on the text, as it is often vague and long-winded. In several examples, I also recommended citing more relevant and recent literature. Additionally, the reviewer has made additional comments for more in-depth analyses of the dataset. I have assessed the manuscript, and I can hardly suggest it for publication for the following reasons: Key critical points are: a) Please check the grammar carefully in the overall manuscript; somewhere it’s written in the past and somewhere in the present and somewhere it needs punctuations. Check the spelling mistakes; there are major spelling errors in the overall document. If possible, please I suggest that this manuscript be reviewed by an English-language expert. Specific Comments 1. The Background section on the body of manuscript: this section needs revision so that it will cover the nature of the core problem, the known aspect of problem (i.e., what is known about the core problem), the unknown aspect of the problem (What is unknown about the core problem), and the expectations from the current study (what and how the current study will add to the existing knowledge). Abstract Background 2. Is that true “Despite the significant progress made in reducing under-five mortality rates across African nations, the mortality rate in this age group continues to be the highest globally.” What does it mean? Please write again? Method 3. “This study employed a multivariable lognormal accelerated failure time gamma shared frailty parametric survival regression analysis to identify the predictors of time-to-death among infants in these African nations.” Is this study for infants? Or for under five children? Conclusion 4. In this study country region, maternal age, maternal education status, maternal age at first birth, respondent's employment status, birth outcome, wealth index, birth order, place of delivery, mode of delivery, women's autonomy in healthcare decision-making, number of antenatal care visits, child's size at birth, sex of the neonate, and community-level women's education. So, what? Please again and again and make a sense? Method 5. The variables used in this study were extracted, cleaned, and processed using STATA version 14 software. Please remove it? This is repetition? 6. When we prepare manuscripts in Plos One no need of “Keywords: survival analysis, accelerated failure time model, Africa.” Please read guide line for Plos One? 7. Please remove the citation style of (1), (2) of endnote style instead of this [1], [2] 8. Please use the latest reference rather than old reference? Like reference 2, 7, 9, 10, 49, 50, 51, 74 …etc… 9. How do you merge these 30 country datasets please give a clear justification? 10. Please include the STATA (version 14) commands that used for final model analysis as appendix (supplementary materials)? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Gebru Gebremeskel Gebrerufael ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Parametric Modeling of Under-5 Children Survival Among 30 African Countries: Lognormal Accelerated Failure Time Gamma Shared Frailty Model PONE-D-24-23176R1 Dear Dr. Liyew, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, James Mockridge Staff Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Title: “Parametric Modeling of Under-5 Children Survival Among 30 African Countries: Lognormal Accelerated Failure Time Gamma Shared Frailty Model” Version: 2 Date: 24-Sep-24 Thank you for the opportunity to review the manuscript entitled ““Parametric Modeling of Under-5 Children Survival Among 30 African Countries: Lognormal Accelerated Failure Time Gamma Shared Frailty Model””. The authors describe a secondary analysis of the dhs dataset to determine the “prevalence and predictors of Under-5 Children among 30 African Countries using Lognormal Accelerated Failure Time Gamma Shared Frailty Model”. This is the second review of this paper following revisions. ∼ The authors have successfully addressed all comments and have vastly improved the article. � I recommend this move forward for publication. Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Gebru Gebremeskel Gebrerufael Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-24-23176R1 PLOS ONE Dear Dr. Liyew, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr James Mockridge Staff Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .